“Pharmacogenomics (PGx) has immense potential in the routine clinical testing space. However, there are many considerations to PGx adoption and scalability within the laboratory. Clinical laboratory leaders are unaware of their laboratory’s readiness, the stages of PGx implementation maturity, and the strategic steps they should take to expand into PGx.
In this Dark Daily webinar with live Q&A, Jeff Shaman, PhD, MS, Chief Science Officer of Coriell Life Sciences will discuss why pharmacogenomics matters and how the COVID health crisis has created unprecedented capacity and acceptance for PGx in laboratory testing.
Up-and-coming and seasoned lab leaders will learn how laboratory technology, science, implementation models, and economic proof points have all achieved deployable maturity for PGx labs. Most importantly, we will define the stages of PGx laboratory implementation maturity and key success points for expanding your laboratory’s PGx testing capacity.”